Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sirot

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Antimicrobial Chemotherapy|April 5, 2000
Clinical relevance of Proteus mirabilis in hospital patients: a two year surveyC de Champs, R Bonnet, D Sirot, et al.
La Nouvelle Presse Medicale|October 21, 1978
[The bactericidal power of antibiotic combinations. Application in the treatment of osteo-articular infections due to Staphylococcus aureus (author's transl)]J Sirot, R Lopitaux, R Cluzel, et al.
Annales De Microbiologie|August 1, 1977
[Rifampicin diffusion in non-infected human bone (author's transl)]J Sirot, R Lopitaux, R Cluzel, et al.
Journal of Clinical Microbiology|December 1, 1987
Spondylitis and osteomyelitis caused by Kingella kingae in childrenC Chanal, F Tiget, P Chapuis, et al.
Pathologie-Biologie|September 1, 1990
[Piperacillin-amikacin combinations: killing curves]M Chanal, J Sirot, C Chanal, et al.
Pathologie-Biologie|May 1, 1988
[Use of ceftazidime combined with netilmicin in the treatment of febrile episodes occurring after bone marrow transplantation in children]C Couturier, B Storme, F Demeocq, et al.
Reviews of Infectious Diseases|July 1, 1988
Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studiesJ Sirot, C Chanal, A Petit, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1994
Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitorsD Sirot, C Chanal, C Henquell, et al.
Pathologie-Biologie|May 1, 1986
[In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values]M Chanal, M Cluzel, D Sirot, et al.
Reviews of Infectious Diseases|July 1, 1988
Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporinsR Labia, A Morand, K Tiwari, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Antimicrobial Chemotherapy|April 5, 2000
Clinical relevance of Proteus mirabilis in hospital patients: a two year surveyC de Champs, R Bonnet, D Sirot, et al.
La Nouvelle Presse Medicale|October 21, 1978
[The bactericidal power of antibiotic combinations. Application in the treatment of osteo-articular infections due to Staphylococcus aureus (author's transl)]J Sirot, R Lopitaux, R Cluzel, et al.
Annales De Microbiologie|August 1, 1977
[Rifampicin diffusion in non-infected human bone (author's transl)]J Sirot, R Lopitaux, R Cluzel, et al.
Journal of Clinical Microbiology|December 1, 1987
Spondylitis and osteomyelitis caused by Kingella kingae in childrenC Chanal, F Tiget, P Chapuis, et al.
Pathologie-Biologie|September 1, 1990
[Piperacillin-amikacin combinations: killing curves]M Chanal, J Sirot, C Chanal, et al.
Pathologie-Biologie|May 1, 1988
[Use of ceftazidime combined with netilmicin in the treatment of febrile episodes occurring after bone marrow transplantation in children]C Couturier, B Storme, F Demeocq, et al.
Reviews of Infectious Diseases|July 1, 1988
Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studiesJ Sirot, C Chanal, A Petit, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1994
Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitorsD Sirot, C Chanal, C Henquell, et al.
Pathologie-Biologie|May 1, 1986
[In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values]M Chanal, M Cluzel, D Sirot, et al.
Reviews of Infectious Diseases|July 1, 1988
Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporinsR Labia, A Morand, K Tiwari, et al.
Pageof 13